Technical Analysis for CTXR - Citius Pharmaceuticals, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 0.72 | -2.20% | -0.02 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Shooting Star Candlestick | Bearish | 0.00% | |
Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
50 DMA Support | Bullish | 0.00% | |
Doji - Bearish? | Reversal | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Crossed Above 50 DMA | Bullish | -2.20% | |
180 Bullish Setup | Bullish Swing Setup | -2.20% | |
Pocket Pivot | Bullish Swing Setup | -2.20% |
Alert | Time |
---|---|
Possible Pocket Pivot | about 12 hours ago |
Reversed from Up | about 13 hours ago |
Rose Above Upper Bollinger Band | about 15 hours ago |
Up 1 ATR | about 15 hours ago |
Rose Above 20 DMA | about 15 hours ago |
Get a Trading Assistant
- Earnings date: 02/08/2024
Citius Pharmaceuticals, Inc. Description
Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care, and prescription products. Its product candidates include Mino-Lok and Hydrocortisone-Lidocaine Cream. The Company's Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. The Company's Hydrocortisone-Lidocaine topical formulation provides anti-inflammation and anesthetic relief to persons suffering from hemorrhoids. Its Mino-Lok product for the treatment of catheter related bloodstream infections has completed Phase IIb and is entering Phase III trials. It is reformulating Hydrocortisone-Lidocaine product and will be entering Phase IIb trials in 2017. As of September 30, 2016, the Company had not generate any revenues.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Drugs Inflammation Catheter Antibiotics Cancer Care Care Products Prescription Product Prescription Products Acetamides Bloodstream Infections Lidocaine
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.71 |
52 Week Low | 0.6 |
Average Volume | 675,845 |
200-Day Moving Average | 0.86 |
50-Day Moving Average | 0.72 |
20-Day Moving Average | 0.74 |
10-Day Moving Average | 0.72 |
Average True Range | 0.05 |
RSI (14) | 48.72 |
ADX | 22.25 |
+DI | 22.29 |
-DI | 19.81 |
Chandelier Exit (Long, 3 ATRs) | 0.70 |
Chandelier Exit (Short, 3 ATRs) | 0.81 |
Upper Bollinger Bands | 0.80 |
Lower Bollinger Band | 0.69 |
Percent B (%b) | 0.29 |
BandWidth | 14.92 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | -0.0054 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.87 | ||||
Resistance 3 (R3) | 0.88 | 0.84 | 0.85 | ||
Resistance 2 (R2) | 0.84 | 0.80 | 0.84 | 0.84 | |
Resistance 1 (R1) | 0.78 | 0.78 | 0.81 | 0.77 | 0.83 |
Pivot Point | 0.74 | 0.74 | 0.76 | 0.74 | 0.74 |
Support 1 (S1) | 0.68 | 0.70 | 0.71 | 0.67 | 0.61 |
Support 2 (S2) | 0.64 | 0.68 | 0.64 | 0.60 | |
Support 3 (S3) | 0.58 | 0.64 | 0.60 | ||
Support 4 (S4) | 0.57 |